CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ABBV

Upadacitinib Oral Product

Phase 3
AbbVie Inc. (ABBV)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
May '27
ABBVPhase 3

Upadacitinib Oral Product Phase 3 Est. Readout (RESCUE UC)

Upadacitinib Oral Product
May 2027~
CT.gov
00%
Competitive Landscape

1 competitor in Colitis, Ulcerative

View Full Landscape
Drug Information

Target Indication

Colitis, Ulcerative

Clinical Trial

NCT06660693

Last updated: 10/29/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.